HLA-C and colorectal cancer: Due to the MHC- and neoantigen-independent function of the γδ-TCR, Vγ9Vδ2 T cells have the potential to indiscriminately kill both MSI and MSS colorectal cancer tumors, rendering them attractive candidates for universal cytotoxicity against all colorectal cancer subsets.